Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · IEX Real-Time Price · USD
17.02
-0.64 (-3.62%)
May 20, 2022 4:00 PM EDT - Market closed
Cash Flow Statement (Quarterly)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Quarter Ended | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|
| Net Income | -12.84 | -11.63 | -8.84 | - | -8.26 | -4.91 | -3.63 |
| Depreciation & Amortization | 0.26 | 0.23 | 0.22 | - | 0.19 | 0.23 | 0.23 |
| Share-Based Compensation | 1.59 | 1.3 | 0.55 | - | 0.19 | 0.18 | 0.19 |
| Other Operating Activities | -4.22 | -1.98 | -0.62 | 0 | 2.75 | 0.75 | -3.4 |
| Operating Cash Flow | -15.2 | -12.09 | -8.69 | - | -5.14 | -3.76 | -6.61 |
| Capital Expenditures | -0.6 | -0.82 | -0.57 | - | -0.07 | -0.13 | -0.1 |
| Change in Investments | -24.9 | 0 | 0 | - | 0 | 0 | 0 |
| Investing Cash Flow | -25.5 | -0.82 | -0.57 | - | -0.07 | -0.13 | -0.1 |
| Share Issuance / Repurchase | 0.02 | 78.74 | 0.02 | - | 0.27 | 0.02 | 0.02 |
| Other Financing Activities | 0 | 1.4 | -1.14 | 0 | 87.22 | 5.12 | 4.78 |
| Financing Cash Flow | 0.02 | 80.14 | -1.12 | - | 87.49 | 5.13 | 4.8 |
| Net Cash Flow | -40.68 | 67.24 | -10.38 | - | 82.28 | 1.24 | -1.46 |
| Free Cash Flow | -15.8 | -12.91 | -9.26 | - | -5.21 | -3.89 | -6.71 |
| Free Cash Flow Per Share | -0.54 | -2.50 | -20.98 | - | -13.01 | -10.22 | -17.82 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).